Patents by Inventor Rebecca Elkington

Rebecca Elkington has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Novel human cytomegalovirus (hcmv) cytotoxic t cell epitopes, polyepitopes compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor
    Publication number: 20050019344
    Abstract: The present invention provides CTL epitope peptides and polyepitope peptides from 14 distinct antigens of human cytomegalovirus (HCMV) that are restricted through HLA the most commonly prevalent class I alleles in different ethnic populations of the world. These epitopes provide an important platform for CTL epitope-based vaccines against HCMV. The present invention further provides vaccine composiitons comprising the subject epitope and polyepitope peptides and methods for vaccination of humans and for the adoptive transfer of HCMV-specific T cells to human subjects. The present invention further provides reagents and methods for determining the HCMV status or level of HCMV-specific immunity of a subject.
    Type: Application
    Filed: June 26, 2002
    Publication date: January 27, 2005
    Inventors: Rajiv Khanna, Rebecca Elkington, Susan Walker